The purchase includes the manufacturing process of four ELISA kits, two of which are in vitro diagnostic products for specialty diagnostics and disease monitoring.
The USP, NIST, and five leading biotech companies participated in a study to compare commonly used techniques to determine ...
The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback